doxazosin

Generic: doxazosin

Labeler: zydus lifesciences limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin
Labeler zydus lifesciences limited
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 2 mg/1

Manufacturer
Zydus Lifesciences Limited

Identifiers & Regulatory

Product NDC 70771-1113
Product ID 70771-1113_466a6bd5-32e1-44ef-8220-90efc2e226d9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208719
Listing Expiration 2026-12-31
Marketing Start 2017-08-31

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707711113
Hyphenated Format 70771-1113

Supplemental Identifiers

RxCUI
197625 197626 197627 197628
UNII
86P6PQK0MU

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin (source: ndc)
Application Number ANDA208719 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (70771-1113-0)
  • 100 TABLET in 1 BOTTLE (70771-1113-1)
  • 30 TABLET in 1 BOTTLE (70771-1113-3)
  • 10 BLISTER PACK in 1 CARTON (70771-1113-4) / 10 TABLET in 1 BLISTER PACK (70771-1113-2)
source: ndc

Packages (4)

Ingredients (1)

doxazosin mesylate (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "466a6bd5-32e1-44ef-8220-90efc2e226d9", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197625", "197626", "197627", "197628"], "spl_set_id": ["ac889877-133c-4448-af5a-d77b3cbfe878"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (70771-1113-0)", "package_ndc": "70771-1113-0", "marketing_start_date": "20170831"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (70771-1113-1)", "package_ndc": "70771-1113-1", "marketing_start_date": "20170831"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (70771-1113-3)", "package_ndc": "70771-1113-3", "marketing_start_date": "20170831"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (70771-1113-4)  / 10 TABLET in 1 BLISTER PACK (70771-1113-2)", "package_ndc": "70771-1113-4", "marketing_start_date": "20170831"}], "brand_name": "Doxazosin", "product_id": "70771-1113_466a6bd5-32e1-44ef-8220-90efc2e226d9", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "70771-1113", "generic_name": "Doxazosin", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "2 mg/1"}], "application_number": "ANDA208719", "marketing_category": "ANDA", "marketing_start_date": "20170831", "listing_expiration_date": "20261231"}